nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—DHCR7—Epirubicin—peripheral nervous system neoplasm	0.15	0.23	CbGbCtD
Tamoxifen—ABCB1—peripheral nervous system neoplasm	0.146	1	CbGaD
Tamoxifen—DHCR7—Doxorubicin—peripheral nervous system neoplasm	0.0795	0.122	CbGbCtD
Tamoxifen—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0225	0.0347	CbGbCtD
Tamoxifen—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0224	0.0346	CbGbCtD
Tamoxifen—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0202	0.031	CbGbCtD
Tamoxifen—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0193	0.0297	CbGbCtD
Tamoxifen—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0166	0.0255	CbGbCtD
Tamoxifen—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0156	0.024	CbGbCtD
Tamoxifen—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0154	0.0237	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0154	0.0237	CbGbCtD
Tamoxifen—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0147	0.0226	CbGbCtD
Tamoxifen—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0128	0.0197	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0126	0.0194	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.0126	0.0194	CbGbCtD
Tamoxifen—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0116	0.0178	CbGbCtD
Tamoxifen—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0111	0.0171	CbGbCtD
Tamoxifen—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0106	0.0163	CbGbCtD
Tamoxifen—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00988	0.0152	CbGbCtD
Tamoxifen—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00971	0.015	CbGbCtD
Tamoxifen—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00958	0.0148	CbGbCtD
Tamoxifen—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.00926	0.0143	CbGbCtD
Tamoxifen—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00894	0.0138	CbGbCtD
Tamoxifen—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00878	0.0135	CbGbCtD
Tamoxifen—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00809	0.0125	CbGbCtD
Tamoxifen—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00809	0.0125	CbGbCtD
Tamoxifen—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00775	0.0119	CbGbCtD
Tamoxifen—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0074	0.0114	CbGbCtD
Tamoxifen—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.00708	0.0109	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.00708	0.0109	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00662	0.0102	CbGbCtD
Tamoxifen—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.00629	0.00968	CbGbCtD
Tamoxifen—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.00626	0.00964	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00599	0.00922	CbGbCtD
Tamoxifen—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00561	0.00864	CbGbCtD
Tamoxifen—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00531	0.00817	CbGbCtD
Tamoxifen—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00486	0.00749	CbGbCtD
Tamoxifen—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00485	0.00747	CbGbCtD
Tamoxifen—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00468	0.0072	CbGbCtD
Tamoxifen—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00451	0.00694	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00421	0.00649	CbGbCtD
Tamoxifen—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00362	0.00558	CbGbCtD
Tamoxifen—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00346	0.00532	CbGbCtD
Tamoxifen—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00332	0.00511	CbGbCtD
Tamoxifen—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00322	0.00496	CbGbCtD
Tamoxifen—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00317	0.00488	CbGbCtD
Tamoxifen—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00216	0.00333	CbGbCtD
Tamoxifen—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00207	0.00319	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00203	0.00313	CbGbCtD
Tamoxifen—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0019	0.00292	CbGbCtD
Tamoxifen—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00199	CbGbCtD
Tamoxifen—Diethylstilbestrol—ABCB1—peripheral nervous system neoplasm	0.00019	0.309	CrCbGaD
Tamoxifen—Toremifene—ABCB1—peripheral nervous system neoplasm	0.000151	0.245	CrCbGaD
Tamoxifen—Clomifene—ABCB1—peripheral nervous system neoplasm	0.00013	0.212	CrCbGaD
Tamoxifen—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.00052	CcSEcCtD
Tamoxifen—Leukopenia—Etoposide—peripheral nervous system neoplasm	8.86e-05	0.000516	CcSEcCtD
Tamoxifen—Pain—Alitretinoin—peripheral nervous system neoplasm	8.85e-05	0.000516	CcSEcCtD
Tamoxifen—Constipation—Alitretinoin—peripheral nervous system neoplasm	8.85e-05	0.000516	CcSEcCtD
Tamoxifen—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	8.82e-05	0.000514	CcSEcCtD
Tamoxifen—Oedema—Cisplatin—peripheral nervous system neoplasm	8.81e-05	0.000514	CcSEcCtD
Tamoxifen—Infection—Cisplatin—peripheral nervous system neoplasm	8.76e-05	0.000511	CcSEcCtD
Tamoxifen—Vomiting—Topotecan—peripheral nervous system neoplasm	8.75e-05	0.00051	CcSEcCtD
Tamoxifen—Mood swings—Epirubicin—peripheral nervous system neoplasm	8.72e-05	0.000509	CcSEcCtD
Tamoxifen—Vomiting—Tretinoin—peripheral nervous system neoplasm	8.68e-05	0.000506	CcSEcCtD
Tamoxifen—Vomiting—Isotretinoin—peripheral nervous system neoplasm	8.68e-05	0.000506	CcSEcCtD
Tamoxifen—Rash—Topotecan—peripheral nervous system neoplasm	8.68e-05	0.000506	CcSEcCtD
Tamoxifen—Dermatitis—Topotecan—peripheral nervous system neoplasm	8.67e-05	0.000505	CcSEcCtD
Tamoxifen—Decreased appetite—Vincristine—peripheral nervous system neoplasm	8.67e-05	0.000505	CcSEcCtD
Tamoxifen—Cough—Etoposide—peripheral nervous system neoplasm	8.63e-05	0.000503	CcSEcCtD
Tamoxifen—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	8.63e-05	0.000503	CcSEcCtD
Tamoxifen—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000503	CcSEcCtD
Tamoxifen—Headache—Topotecan—peripheral nervous system neoplasm	8.62e-05	0.000503	CcSEcCtD
Tamoxifen—Rash—Isotretinoin—peripheral nervous system neoplasm	8.61e-05	0.000502	CcSEcCtD
Tamoxifen—Rash—Tretinoin—peripheral nervous system neoplasm	8.61e-05	0.000502	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	8.61e-05	0.000502	CcSEcCtD
Tamoxifen—Dermatitis—Tretinoin—peripheral nervous system neoplasm	8.6e-05	0.000501	CcSEcCtD
Tamoxifen—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	8.6e-05	0.000501	CcSEcCtD
Tamoxifen—Fatigue—Vincristine—peripheral nervous system neoplasm	8.59e-05	0.000501	CcSEcCtD
Tamoxifen—Vomiting—Melphalan—peripheral nervous system neoplasm	8.57e-05	0.000499	CcSEcCtD
Tamoxifen—Headache—Tretinoin—peripheral nervous system neoplasm	8.55e-05	0.000499	CcSEcCtD
Tamoxifen—Headache—Isotretinoin—peripheral nervous system neoplasm	8.55e-05	0.000499	CcSEcCtD
Tamoxifen—Hypertension—Etoposide—peripheral nervous system neoplasm	8.54e-05	0.000498	CcSEcCtD
Tamoxifen—Pain—Vincristine—peripheral nervous system neoplasm	8.52e-05	0.000497	CcSEcCtD
Tamoxifen—Constipation—Vincristine—peripheral nervous system neoplasm	8.52e-05	0.000497	CcSEcCtD
Tamoxifen—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000497	CcSEcCtD
Tamoxifen—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	8.52e-05	0.000497	CcSEcCtD
Tamoxifen—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000496	CcSEcCtD
Tamoxifen—Rash—Melphalan—peripheral nervous system neoplasm	8.5e-05	0.000495	CcSEcCtD
Tamoxifen—Dermatitis—Melphalan—peripheral nervous system neoplasm	8.49e-05	0.000495	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	8.46e-05	0.000493	CcSEcCtD
Tamoxifen—Chest pain—Etoposide—peripheral nervous system neoplasm	8.42e-05	0.000491	CcSEcCtD
Tamoxifen—Anorexia—Cisplatin—peripheral nervous system neoplasm	8.4e-05	0.00049	CcSEcCtD
Tamoxifen—Loperamide—ABCB1—peripheral nervous system neoplasm	8.37e-05	0.136	CrCbGaD
Tamoxifen—Discomfort—Etoposide—peripheral nervous system neoplasm	8.32e-05	0.000485	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000484	CcSEcCtD
Tamoxifen—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	8.22e-05	0.000479	CcSEcCtD
Tamoxifen—Urticaria—Alitretinoin—peripheral nervous system neoplasm	8.22e-05	0.000479	CcSEcCtD
Tamoxifen—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	8.18e-05	0.000477	CcSEcCtD
Tamoxifen—Nausea—Topotecan—peripheral nervous system neoplasm	8.17e-05	0.000477	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	8.15e-05	0.000475	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.000474	CcSEcCtD
Tamoxifen—Nausea—Tretinoin—peripheral nervous system neoplasm	8.11e-05	0.000473	CcSEcCtD
Tamoxifen—Nausea—Isotretinoin—peripheral nervous system neoplasm	8.11e-05	0.000473	CcSEcCtD
Tamoxifen—Mood swings—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.000471	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	8.03e-05	0.000468	CcSEcCtD
Tamoxifen—Infection—Etoposide—peripheral nervous system neoplasm	8.02e-05	0.000468	CcSEcCtD
Tamoxifen—Asthenia—Dactinomycin—peripheral nervous system neoplasm	8e-05	0.000467	CcSEcCtD
Tamoxifen—Nausea—Melphalan—peripheral nervous system neoplasm	8e-05	0.000467	CcSEcCtD
Tamoxifen—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000465	CcSEcCtD
Tamoxifen—Influenza—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000464	CcSEcCtD
Tamoxifen—Dysphagia—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000464	CcSEcCtD
Tamoxifen—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	7.91e-05	0.000461	CcSEcCtD
Tamoxifen—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	7.91e-05	0.000461	CcSEcCtD
Tamoxifen—Abdominal pain—Vincristine—peripheral nervous system neoplasm	7.88e-05	0.000459	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000459	CcSEcCtD
Tamoxifen—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	7.86e-05	0.000458	CcSEcCtD
Tamoxifen—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	7.81e-05	0.000455	CcSEcCtD
Tamoxifen—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000455	CcSEcCtD
Tamoxifen—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000452	CcSEcCtD
Tamoxifen—Anorexia—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000449	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000447	CcSEcCtD
Tamoxifen—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	7.66e-05	0.000447	CcSEcCtD
Tamoxifen—Bronchitis—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000446	CcSEcCtD
Tamoxifen—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	7.63e-05	0.000445	CcSEcCtD
Tamoxifen—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	7.62e-05	0.000444	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	7.61e-05	0.000444	CcSEcCtD
Tamoxifen—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000441	CcSEcCtD
Tamoxifen—Pain—Cisplatin—peripheral nervous system neoplasm	7.54e-05	0.000439	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000438	CcSEcCtD
Tamoxifen—Neutropenia—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000434	CcSEcCtD
Tamoxifen—Asthenia—Alitretinoin—peripheral nervous system neoplasm	7.42e-05	0.000433	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000429	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000429	CcSEcCtD
Tamoxifen—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	7.34e-05	0.000428	CcSEcCtD
Tamoxifen—Pruritus—Alitretinoin—peripheral nervous system neoplasm	7.32e-05	0.000427	CcSEcCtD
Tamoxifen—Paraesthesia—Etoposide—peripheral nervous system neoplasm	7.25e-05	0.000423	CcSEcCtD
Tamoxifen—Weight increased—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000422	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000421	CcSEcCtD
Tamoxifen—Weight decreased—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.00042	CcSEcCtD
Tamoxifen—Dyspnoea—Etoposide—peripheral nervous system neoplasm	7.2e-05	0.00042	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000418	CcSEcCtD
Tamoxifen—Asthenia—Vincristine—peripheral nervous system neoplasm	7.15e-05	0.000417	CcSEcCtD
Tamoxifen—Pneumonia—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.000416	CcSEcCtD
Tamoxifen—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.09e-05	0.000414	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.000413	CcSEcCtD
Tamoxifen—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.08e-05	0.000413	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.00041	CcSEcCtD
Tamoxifen—Rash—Dactinomycin—peripheral nervous system neoplasm	7.03e-05	0.00041	CcSEcCtD
Tamoxifen—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.02e-05	0.000409	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000408	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	6.97e-05	0.000406	CcSEcCtD
Tamoxifen—Fatigue—Etoposide—peripheral nervous system neoplasm	6.96e-05	0.000406	CcSEcCtD
Tamoxifen—Pain—Etoposide—peripheral nervous system neoplasm	6.91e-05	0.000403	CcSEcCtD
Tamoxifen—Constipation—Etoposide—peripheral nervous system neoplasm	6.91e-05	0.000403	CcSEcCtD
Tamoxifen—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000402	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000402	CcSEcCtD
Tamoxifen—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.84e-05	0.000399	CcSEcCtD
Tamoxifen—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.82e-05	0.000398	CcSEcCtD
Tamoxifen—Sweating—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000397	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000391	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000388	CcSEcCtD
Tamoxifen—Sinusitis—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.000388	CcSEcCtD
Tamoxifen—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.63e-05	0.000386	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000385	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	6.6e-05	0.000385	CcSEcCtD
Tamoxifen—Dizziness—Vincristine—peripheral nervous system neoplasm	6.59e-05	0.000384	CcSEcCtD
Tamoxifen—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.58e-05	0.000383	CcSEcCtD
Tamoxifen—Rash—Alitretinoin—peripheral nervous system neoplasm	6.52e-05	0.00038	CcSEcCtD
Tamoxifen—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.52e-05	0.00038	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.00038	CcSEcCtD
Tamoxifen—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.49e-05	0.000379	CcSEcCtD
Tamoxifen—Headache—Alitretinoin—peripheral nervous system neoplasm	6.48e-05	0.000378	CcSEcCtD
Tamoxifen—Urticaria—Etoposide—peripheral nervous system neoplasm	6.41e-05	0.000374	CcSEcCtD
Tamoxifen—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000373	CcSEcCtD
Tamoxifen—Abdominal pain—Etoposide—peripheral nervous system neoplasm	6.38e-05	0.000372	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000372	CcSEcCtD
Tamoxifen—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000371	CcSEcCtD
Tamoxifen—Hepatitis—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000371	CcSEcCtD
Tamoxifen—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.00037	CcSEcCtD
Tamoxifen—Vomiting—Vincristine—peripheral nervous system neoplasm	6.34e-05	0.00037	CcSEcCtD
Tamoxifen—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.32e-05	0.000369	CcSEcCtD
Tamoxifen—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000369	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.000367	CcSEcCtD
Tamoxifen—Rash—Vincristine—peripheral nervous system neoplasm	6.29e-05	0.000366	CcSEcCtD
Tamoxifen—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.28e-05	0.000366	CcSEcCtD
Tamoxifen—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000366	CcSEcCtD
Tamoxifen—Headache—Vincristine—peripheral nervous system neoplasm	6.24e-05	0.000364	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000359	CcSEcCtD
Tamoxifen—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.14e-05	0.000358	CcSEcCtD
Tamoxifen—Visual impairment—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000358	CcSEcCtD
Tamoxifen—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.03e-05	0.000352	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.02e-05	0.000351	CcSEcCtD
Tamoxifen—Methadone—ABCB1—peripheral nervous system neoplasm	5.96e-05	0.0971	CrCbGaD
Tamoxifen—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	5.95e-05	0.000347	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000345	CcSEcCtD
Tamoxifen—Nausea—Vincristine—peripheral nervous system neoplasm	5.92e-05	0.000345	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000345	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000344	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000344	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000342	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000341	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000339	CcSEcCtD
Tamoxifen—Asthenia—Etoposide—peripheral nervous system neoplasm	5.79e-05	0.000338	CcSEcCtD
Tamoxifen—Pruritus—Etoposide—peripheral nervous system neoplasm	5.71e-05	0.000333	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000332	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000331	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000328	CcSEcCtD
Tamoxifen—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.6e-05	0.000327	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	0.000325	CcSEcCtD
Tamoxifen—Rash—Cisplatin—peripheral nervous system neoplasm	5.56e-05	0.000324	CcSEcCtD
Tamoxifen—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.55e-05	0.000324	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000323	CcSEcCtD
Tamoxifen—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.52e-05	0.000322	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000319	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000317	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000313	CcSEcCtD
Tamoxifen—Dizziness—Etoposide—peripheral nervous system neoplasm	5.34e-05	0.000311	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000311	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.000307	CcSEcCtD
Tamoxifen—Nausea—Cisplatin—peripheral nervous system neoplasm	5.24e-05	0.000305	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000304	CcSEcCtD
Tamoxifen—Vomiting—Etoposide—peripheral nervous system neoplasm	5.13e-05	0.000299	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000299	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000299	CcSEcCtD
Tamoxifen—Rash—Etoposide—peripheral nervous system neoplasm	5.09e-05	0.000297	CcSEcCtD
Tamoxifen—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.09e-05	0.000297	CcSEcCtD
Tamoxifen—Headache—Etoposide—peripheral nervous system neoplasm	5.06e-05	0.000295	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000293	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000289	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000289	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000288	CcSEcCtD
Tamoxifen—Cough—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000282	CcSEcCtD
Tamoxifen—Nausea—Etoposide—peripheral nervous system neoplasm	4.8e-05	0.00028	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000279	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000277	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000275	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000275	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000275	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000274	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000272	CcSEcCtD
Tamoxifen—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.62e-05	0.000269	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000268	CcSEcCtD
Tamoxifen—Oedema—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000264	CcSEcCtD
Tamoxifen—Infection—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000262	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000261	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000258	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000258	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.000255	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000255	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000255	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000255	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000254	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000252	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000252	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000249	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000244	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000243	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.00024	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000239	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000239	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000237	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000236	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000235	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000233	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000232	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.000229	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.91e-05	0.000228	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000228	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000226	CcSEcCtD
Tamoxifen—Pain—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000226	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000222	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.000221	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000219	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000218	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000216	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000215	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000212	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000211	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000211	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.00021	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000209	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000209	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000209	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.0002	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000194	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000194	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000193	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000189	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000187	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.1e-05	0.000181	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.00018	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000175	CcSEcCtD
Tamoxifen—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000175	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000173	CcSEcCtD
Tamoxifen—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000168	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.87e-05	0.000167	CcSEcCtD
Tamoxifen—Rash—Epirubicin—peripheral nervous system neoplasm	2.85e-05	0.000166	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.85e-05	0.000166	CcSEcCtD
Tamoxifen—Headache—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000165	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000161	CcSEcCtD
Tamoxifen—Nausea—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000157	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000155	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—peripheral nervous system neoplasm	2.64e-05	0.000154	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.64e-05	0.000154	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—peripheral nervous system neoplasm	2.62e-05	0.000153	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000145	CcSEcCtD
Tamoxifen—CYP1B1—Metabolism—GNS—peripheral nervous system neoplasm	2.25e-05	0.000702	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	2.24e-05	0.000699	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	2.22e-05	0.000692	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.21e-05	0.000687	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.18e-05	0.00068	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—NME1—peripheral nervous system neoplasm	2.16e-05	0.000673	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	2.16e-05	0.000673	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.15e-05	0.000671	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.14e-05	0.000666	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.14e-05	0.000666	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.12e-05	0.000661	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—COX2—peripheral nervous system neoplasm	2.08e-05	0.000648	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	2.08e-05	0.000648	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.08e-05	0.000648	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.05e-05	0.00064	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.05e-05	0.000639	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.03e-05	0.000634	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	2.03e-05	0.000633	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.03e-05	0.000633	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—TH—peripheral nervous system neoplasm	2.02e-05	0.000631	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.98e-05	0.000616	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GNAS—peripheral nervous system neoplasm	1.97e-05	0.000614	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.96e-05	0.000612	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	1.95e-05	0.000607	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000605	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.93e-05	0.000603	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.92e-05	0.000598	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	1.91e-05	0.000594	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.89e-05	0.000589	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	1.88e-05	0.000585	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.87e-05	0.000584	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	1.86e-05	0.00058	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.81e-05	0.000564	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	1.78e-05	0.000556	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.78e-05	0.000556	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.76e-05	0.000548	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.75e-05	0.000546	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.72e-05	0.000537	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.72e-05	0.000536	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	1.72e-05	0.000535	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	1.71e-05	0.000532	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.7e-05	0.000529	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.69e-05	0.000526	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.68e-05	0.000523	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.65e-05	0.000515	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	1.62e-05	0.000506	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.62e-05	0.000505	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.61e-05	0.000502	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.59e-05	0.000497	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	1.59e-05	0.000495	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.57e-05	0.000489	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.53e-05	0.000478	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.51e-05	0.000472	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	1.5e-05	0.000468	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	1.49e-05	0.000465	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.48e-05	0.000461	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	1.47e-05	0.000459	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.47e-05	0.000458	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.46e-05	0.000456	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.44e-05	0.00045	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.44e-05	0.000449	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	1.44e-05	0.000449	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	1.43e-05	0.000447	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.43e-05	0.000446	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.42e-05	0.000442	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.41e-05	0.000441	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	1.41e-05	0.00044	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.41e-05	0.000439	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.4e-05	0.000436	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.39e-05	0.000432	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	1.39e-05	0.000432	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.36e-05	0.000425	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	1.36e-05	0.000423	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.35e-05	0.000422	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.33e-05	0.000414	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.33e-05	0.000414	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.3e-05	0.000407	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.29e-05	0.000401	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—MYC—peripheral nervous system neoplasm	1.28e-05	0.0004	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.28e-05	0.000399	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.27e-05	0.000396	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.24e-05	0.000387	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.23e-05	0.000384	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.22e-05	0.000382	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.22e-05	0.000381	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.22e-05	0.00038	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	1.22e-05	0.00038	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.2e-05	0.000373	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.2e-05	0.000373	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000372	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.19e-05	0.000371	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.17e-05	0.000366	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.17e-05	0.000364	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.16e-05	0.00036	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.15e-05	0.000359	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000356	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.14e-05	0.000354	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	1.13e-05	0.000352	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	1.13e-05	0.000351	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.11e-05	0.000345	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.1e-05	0.000343	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.09e-05	0.000339	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	1.08e-05	0.000338	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.06e-05	0.000331	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.05e-05	0.000327	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.05e-05	0.000326	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.04e-05	0.000325	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	0.000324	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.03e-05	0.000323	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.02e-05	0.000319	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.02e-05	0.000317	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1e-05	0.000312	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1e-05	0.000312	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	9.92e-06	0.000309	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.92e-06	0.000309	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	9.86e-06	0.000307	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	9.78e-06	0.000305	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	9.63e-06	0.0003	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	9.55e-06	0.000298	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	9.53e-06	0.000297	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.44e-06	0.000294	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.29e-06	0.00029	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.2e-06	0.000287	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	9.19e-06	0.000286	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—AKT1—peripheral nervous system neoplasm	9.13e-06	0.000285	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.11e-06	0.000284	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	9.1e-06	0.000284	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.09e-06	0.000283	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.02e-06	0.000281	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	8.96e-06	0.000279	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	8.96e-06	0.000279	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	8.91e-06	0.000278	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—AKT1—peripheral nervous system neoplasm	8.9e-06	0.000277	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	8.89e-06	0.000277	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	8.85e-06	0.000276	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	8.84e-06	0.000276	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.68e-06	0.000271	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—AKT1—peripheral nervous system neoplasm	8.66e-06	0.00027	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	8.55e-06	0.000267	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	8.48e-06	0.000264	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	8.4e-06	0.000262	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MYC—peripheral nervous system neoplasm	8.17e-06	0.000255	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	8.16e-06	0.000254	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	8.05e-06	0.000251	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	7.98e-06	0.000249	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.9e-06	0.000246	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.87e-06	0.000245	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	7.83e-06	0.000244	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	7.7e-06	0.00024	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	7.69e-06	0.00024	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	7.53e-06	0.000235	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	7.52e-06	0.000234	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.5e-06	0.000234	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.48e-06	0.000233	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—AKT1—peripheral nervous system neoplasm	7.44e-06	0.000232	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.34e-06	0.000229	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	7.31e-06	0.000228	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	7.23e-06	0.000225	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.18e-06	0.000224	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.18e-06	0.000224	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.17e-06	0.000223	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	7.1e-06	0.000221	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	7.08e-06	0.000221	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	7.07e-06	0.00022	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—AKT1—peripheral nervous system neoplasm	6.92e-06	0.000216	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.88e-06	0.000214	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	6.88e-06	0.000214	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	6.83e-06	0.000213	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.77e-06	0.000211	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.71e-06	0.000209	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	6.68e-06	0.000208	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.54e-06	0.000204	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	6.51e-06	0.000203	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	6.32e-06	0.000197	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.32e-06	0.000197	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.3e-06	0.000196	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	6.27e-06	0.000195	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.21e-06	0.000194	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	6.12e-06	0.000191	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	5.9e-06	0.000184	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	5.81e-06	0.000181	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.79e-06	0.000181	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	5.78e-06	0.00018	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	5.77e-06	0.00018	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.67e-06	0.000177	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.67e-06	0.000177	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—AKT1—peripheral nervous system neoplasm	5.66e-06	0.000177	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.66e-06	0.000176	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.54e-06	0.000173	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	5.46e-06	0.00017	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	5.45e-06	0.00017	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.41e-06	0.000169	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	5.36e-06	0.000167	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.35e-06	0.000167	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	5.34e-06	0.000167	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.33e-06	0.000166	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—peripheral nervous system neoplasm	5.32e-06	0.000166	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.3e-06	0.000165	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.1e-06	0.000159	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.05e-06	0.000158	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.02e-06	0.000157	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5e-06	0.000156	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	4.98e-06	0.000155	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	4.9e-06	0.000153	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.78e-06	0.000149	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.53e-06	0.000141	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	4.46e-06	0.000139	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.46e-06	0.000139	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.38e-06	0.000136	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.35e-06	0.000136	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.32e-06	0.000135	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	4.26e-06	0.000133	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.14e-06	0.000129	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	4.12e-06	0.000128	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.1e-06	0.000128	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.07e-06	0.000127	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.03e-06	0.000125	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	3.99e-06	0.000124	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.78e-06	0.000118	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.49e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.47e-06	0.000108	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.43e-06	0.000107	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.41e-06	0.000106	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.33e-06	0.000104	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	3.29e-06	0.000102	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.29e-06	0.000102	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.87e-06	8.96e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	2.86e-06	8.9e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.68e-06	8.36e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.68e-06	8.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.63e-06	8.2e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-06	7.73e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.39e-06	7.45e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.2e-06	6.85e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.17e-06	6.77e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.15e-06	6.71e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.1e-06	6.55e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	1.97e-06	6.15e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.86e-06	5.79e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-06	4.97e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-06	4.86e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-06	4.85e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.47e-06	4.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.35e-06	4.2e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.2e-06	3.75e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-06	3.66e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.11e-06	3.45e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.1e-06	3.42e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	9.38e-07	2.92e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.24e-07	2.26e-05	CbGpPWpGaD
